Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115025) titled 'Evaluation of the Efficacy of Helicobacter pylori Eradication Therapy in Autoimmune Gastritis with Coexisting Infection' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Autoimmune Gastritis
Intervention:
immediate H. pylori eradication group:Research participants randomized to the immediate H. pylori eradication group will receive a standard course of bismuth-containing quadruple therapy promptly after enrollment
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sam...